Live Breaking News & Updates on Nuvation Bio

Stay updated with breaking news from Nuvation bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nuvation Bio Inc. (NYSE:NUVB) Director Acquires $499,348.10 in Stock

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) Director Kim D. Blickenstaff purchased 172,189 shares of the company’s stock in a transaction on Tuesday, June 11th. The stock was purchased at an average cost of $2.90 per share, for a total transaction of $499,348.10. Following the purchase, the director now directly owns 172,189 shares in […] ....

Canada , Kimd-blickenstaff , Nuvation-bio , Royal-bank , Nuvation-bio-inc , Jacobs-levy-equity-management-inc , Pricet-rowe-associates-inc , Vanguard-group-inc , Jefferies-financial-group , Acadian-asset-management , Get-free-report , Director-kim

Weekly Analysts' Ratings Updates for Nuvation Bio (NUVB)

Nuvation Bio (NYSE: NUVB) recently received a number of ratings updates from brokerages and research firms: 6/3/2024 – Nuvation Bio had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock. 5/24/2024 – Nuvation Bio had its “outperform” rating reaffirmed by analysts at Wedbush. They now […] ....

Canada , Nuvation-bio , Beacon-pointe-advisors , Pinnacle-wealth-planning-services-inc , Nuvation-bio-inc , News-ratings-for-nuvation-bio-inc-daily , Royal-bank , Susquehanna-fundamental-investments , Exchange-traded-concepts , Get-free-report , Pointe-advisors , Fundamental-investments

Nuvation Bio (NYSE:NUVB) Shares Down 7.7%

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report)’s share price fell 7.7% on Monday . The company traded as low as $2.85 and last traded at $2.86. 677,357 shares were traded during mid-day trading, a decline of 44% from the average session volume of 1,220,003 shares. The stock had previously closed at $3.10. Analyst Upgrades […] ....

Canada , Nuvation-bio , Nuvation-bio-inc , Jefferies-financial-group , Beacon-pointe-advisors , Pinnacle-wealth-planning-services-inc , Exchange-traded-concepts , Royal-bank , Susquehanna-fundamental-investments , Get-free-report , Pointe-advisors , Fundamental-investments

Nuvation Bio (NYSE:NUVB) Shares Down 7.7%

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report)’s share price fell 7.7% on Monday . The company traded as low as $2.85 and last traded at $2.86. 677,357 shares were traded during mid-day trading, a decline of 44% from the average session volume of 1,220,003 shares. The stock had previously closed at $3.10. Analyst Upgrades […] ....

Canada , Nuvation-bio , Exchange-traded-concepts , Royal-bank , Pinnacle-wealth-planning-services-inc , Susquehanna-fundamental-investments , Nuvation-bio-inc , Beacon-pointe-advisors , Jefferies-financial-group , Get-free-report , Pointe-advisors , Fundamental-investments

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company… ....

China , Tongji , Sichuan , Suzhou , Jiangsu , Rhui-zhou , Guangdong , United-states , Hong-kong , Shanghai , Taiwan , Macau